BiDil Approval History
FDA Approved: Yes (First approved June 23, 2005)
Brand name: BiDil
Generic name: isosorbide dinitrate and hydralazine
Dosage form: Tablets
Company: NitroMed, Inc.
Treatment for: Heart Failure
BiDil is a fixed-dose combination of isosorbide dinitrate (a vasodilator) and hydralazine hydrochloride (an arterial dilator) indicated for the treatment of heart failure in black patients.